30 yrs female presented with unilateral breast cancer associated with axilary lymph node enlargement. Modified radical mastectomy was done, further treatment plan will be
**Question:** A 30-year-old female presents with a unilateral breast cancer along with axillary lymph node enlargement. A modified radical mastectomy is performed, and the subsequent treatment plan will be
A. Chemotherapy
B. Radiotherapy
C. Hormone therapy
D. Targeted therapy
**Core Concept:** In patients with breast cancer, axillary lymph node involvement signifies a higher stage of disease, indicating a greater likelihood of systemic disease spread. Consequently, the treatment plan involves a combination of modalities to combat both the primary tumor and potential micrometastases.
**Why the Correct Answer is Right:** Post-mastectomy, the subsequent treatment plan comprises of:
A. Chemotherapy: Breast cancer cells often release substances that stimulate the growth of nearby and distant cells, leading to the formation of secondary tumors. Chemotherapy drugs target rapidly dividing cells, effectively reducing the risk of distant recurrence.
B. Radiotherapy: Breast cancer cells can hide within the breast tissue and axillary lymph nodes, making it difficult to eradicate them completely. Radiotherapy delivers high-energy radiation to these areas, destroying cancer cells and preventing local recurrence.
C. Hormone therapy: Breast cancer cells can be influenced by hormones (estrogen and progesterone) in the body, which promotes their growth. Hormone therapy targets these hormones or their receptors, halting the cancer cells' growth and reducing the risk of distant recurrence.
D. Targeted therapy: Targeted therapies aim to specifically inhibit cancer cell growth by targeting specific molecules or pathways involved in cancer development and progression. In the context of breast cancer, targeted therapies can be used in combination with other treatments to enhance their effectiveness.
**Why Each Wrong Option is Incorrect:**
Option A (Targeted therapy) is incorrect because targeted therapies are more effective when combined with other treatments, not used as a standalone modality. Therefore, it is often recommended after chemotherapy and/or hormone therapy to enhance treatment outcomes.
Option B (Hormone therapy) is incorrect as hormone therapy is indicated in patients with hormone receptor-positive breast cancer, not post-mastectomy patients. In this case, radiotherapy is more suitable for preventing local recurrence.
Option D (Targeted therapy) is incorrect because targeted therapies are typically prescribed after chemotherapy and/or hormone therapy to further improve treatment results. In this instance, hormone therapy is more appropriate for post-mastectomy patients.
Option C (Chemotherapy) is incorrect as chemotherapy is usually administered to patients with breast cancer before or during surgery, not after surgery as a post-mastectomy treatment. Hormone therapy is more suitable for post-mastectomy patients.
**Clinical Pearl:** The correct sequence of treatments for post-mastectomy breast cancer patients is radiotherapy, hormone therapy, and, if indicated, chemotherapy. Targeted therapy is usually administered after chemotherapy and/or hormone therapy.